Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors.

Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors.

Item
http://www.wikidata.org/entity/Q38831440
The role of the ALK receptor in cancer biologyOncogenic kinase fusions: an evolving arena with innovative clinical opportunitiesAnti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK.Maternal Immunization: New Perspectives on Its Application Against Non-Infectious Related Diseases in Newborns.Epitope mapping of spontaneous autoantibodies to anaplastic lymphoma kinase (ALK) in non-small cell lung cancer.Non-Canonical Thinking for Targeting ALK-Fusion Onco-Proteins in Lung Cancer.Targeting tumour microenvironment by tyrosine kinase inhibitor.Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes.Composite biomarkers defined by multiparametric immunofluorescence analysis identify ALK-positive adenocarcinoma as a potential target for immunotherapy.Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.Autochthonous murine models for the study of smoker and never-smoker associated lung cancers
P2860

Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors.

Item
http://www.wikidata.org/entity/Q38831440
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors.
@en
type
label
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors.
@en
prefLabel
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors
@en
P2093
P2860
P304
P31
P356
10.1158/2326-6066.CIR-15-0089
P433
P478
P50
P577
P5875
P698
P932